BIO EUROPE 2019
What Is It All About?
BioEurope is the largest Biotechnology partnering conference held in Europe. Last year saw more than 4000 delegates from all over the world attending the conference to find the best suitable partners and seeking advice from Life Sciences consulting companies for their business growth. With the active participation of more than 2300 companies from Life Science vertical from over 60 countries, the conference provides a platform to the companies to understand the trends in the Biotechnology market. The conference focuses on the need for the innovation and novel treatment methods and helps companies across the biotech value chain to strategize their moves.
Schedule A One-To-One Meeting with Our Delegates At BIO-Europe 2019.
The 3-day event offers a plethora of opportunities in one place. The startup companies gain valuable insights in the form of open-knowledge presentations and opinions from subject-matter experts.
BIO-Europe is a social platform that helps companies to mark the opportunities and grab them yielding the best output.
Share:
Business Development
We are advising our clients to expand their business by entering the lucrative Pharma market in Japan by analyzing market trends and presenting a calculated forecast. Our clients from different geographies, including EU5, US, LATAM, and others have stepped into Japan’s pharma market for the development of their Business. Similarly, our clients from Japan are exploring the markets in other geographies.
Market Assessment
We are providing indication-based reports that are customized and made geography-specific for the clients to suit their requirements. Our analysts carry out extensive primary and secondary research to focus on the geography of interest and offer Epidemiological, and Market landscape along with the market drivers and barriers.
In/Out-Licensing Opportunities
We are also proffering potential licensing opportunities in the pharma market, specifically in Japan for the ease of development of drug candidate and its commercialization in the respective geography.
Partner Identification
Our analysts are helping the clients in identifying potential Japan-based partners to help them grow their business. Our clients from different regions are excelling in this fast-paced pharma market by forming alliances and signing deals with the pharma companies based in Japan. Similarly, our clients from Japan are increasing their foothold overseas.
Mergers/Acquisitions
We are offering business methods for our clients through different business expansion moves like mergers, collaborations, and acquisitions in Japan. Our clients from the US, EU5, and other emerging markets are acquiring and forming partnerships with others in Japan to kick-start their business in geography. Similarly, our strong network is offering Pharmaceuticals in Japan an opportunity to establish their foundation outside Japan.
Regulatory Analysis
We are providing our clients with a thorough understanding of the regulatory authority of the region, about the guidelines for conducting clinical trials, getting approval and market commercialization. We explain to our clients based in other regions about the guidelines laid by The Pharmaceuticals and Medical Devices Agency (PMDA), government regulatory organization in Japan.
Share:
We invite you to discuss your business-related concerns, and together we can find the best possible solution to help you advance in the Biotechnology market.
Share:
The BioEurope 2019 took place at the major port and the most livable city of Germany, Hamburg, which is home to some of the best architectures in the world.
Share:
Counting Down
-